Merger19 Aug 2026, 05:10 pm
Cipla Receives NCLT Order for Inzpera Healthsciences Amalgamation
AI Summary
Cipla Limited has received an order from the Hon'ble National Company Law Tribunal (NCLT), Mumbai Bench, approving the Scheme of Amalgamation of its wholly-owned subsidiary, Inzpera Healthsciences Limited, with Cipla Limited. The order, dated August 18, 2026, allows the amalgamation with specific directions. The scheme was approved by the respective Boards on March 19, 2026, with an Appointed Date of April 1, 2026. The amalgamation aims to consolidate resources, improve operational efficiency, enhance shareholder value, and reduce compliance costs.
Key Highlights
- NCLT Mumbai approves amalgamation of Inzpera Healthsciences with Cipla.
- Scheme of Amalgamation effective from April 1, 2026.
- Aims for resource consolidation and operational efficiency.
- Expected to enhance shareholder value and reduce compliance costs.
Price Impact
More from CIPLA